SEC Form 4
Parabilis Medicines, Inc. (PBLS) insider trading
In the 12 months to Nov 19, 2026, 4 PBLS insiders reported open-market purchases of $441.4M across 6 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $441.4M
- 6 filings
Who traded PBLS, and when
- Purchase
PBLS daily close from Jun 10, 2026 to Nov 18, 2026, between $22.75 and $41.73, last $28.47. 0 sale and 6 purchase filings by 4 insiders, marked at their filing dates. Peter Kolchinsky, Director: bought $426.0M across 2 filings, first filed Jun 15, 2026, last Jul 22, 2026. Guy Levy, 10% owner: bought $10.0M across 1 filing, first filed Jun 29, 2026, last Jun 29, 2026. Rajeev M. Shah, Director: bought $4.7M across 1 filing, first filed Jul 22, 2026, last Jul 22, 2026. Alan Sebulsky, Director: bought $723.5K across 2 filings, first filed Jun 15, 2026, last Jun 16, 2026.
Largest mark · tap a row for others
Peter Kolchinsky · Director
Purchase $423,775,000
21,188,750 shares at $20.00 avg
Filed Jun 15, 2026 · traded Jun 11
Close on filing date $25.01
Peter Kolchinsky · Director
Director
$426.0M boughtGuy Levy · 10% owner
10% owner
$10.0M boughtRajeev M. Shah · Director
Director
$4.7M boughtAlan Sebulsky · Director
Director
$723.5K boughtOpen-market trades
6 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Peter Kolchinsky | Director | — | $426.0M | 2 | — | |
| Guy Levy | 10% owner | — | $10.0M | 1 | — | |
| Rajeev M. Shah | Director | — | $4.7M | 1 | — | |
| Alan Sebulsky | Director | — | $723.5K | 2 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Peter Kolchinsky Director | Purchase | 77,214 | $28.96 | $2.2M | 26,482,436 | |
traded | Rajeev M. Shah Director | Purchase | 167,379 | $27.98 | $4.7M | 26,529,686 | |
traded | Guy Levy 10% owner | Purchase | 500,000 | $20.00 | $10.0M | 1,027,000 | |
traded | Alan Sebulsky Director | Purchase | 17,500 | $27.06 | $473.5K | 30,000 | |
traded | Alan Sebulsky Director | Purchase | 12,500 | $20.00 | $250.0K | 12,500 | |
traded | Peter Kolchinsky Director | Purchase | 21,188,750 | $20.00 | $423.8M | 26,285,093 |
GET /stocks/filings/vX/form-4?tickers=PBLS&filing_date.gte=2025-11-19&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"PBLS"
],
"issuer_cik": "0001657677",
"owner_cik": "0001346824",
"accession_number": "0001231919-26-000779",
"form_type": "4",
"filing_date": "2026-07-22",
"period_of_report": "2026-07-20",
"issuer_name": "Parabilis Medicines, Inc.",
"issuer_trading_symbol": "PBLS",
"owner_name": "RA CAPITAL MANAGEMENT, L.P.",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Voting Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-07-21",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 21696,
"transaction_price_per_share": 27.96,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 26438209,
"transaction_value": 606620.16,
"direct_or_indirect": "I",
"nature_of_ownership": "See footnotes",
"footnotes": [
{
"id": "F5",
"description": "The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $27.46 to $28.34 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."
},
{
"id": "F2",
"description": "RA Capital Management, L.P. (the \"Adviser\") is the investment manager for RA Capital Healthcare Fund, L.P. (the \"Fund\") and RA Capital Nexus Fund III, L.P. (the \"Nexus Fund III\"). The general partner of the Adviser is RA Capital Management GP, LLC (the \"Adviser GP\"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein."
},
{
"id": "F3",
"description": "Held directly by the Fund."
}
],
"remarks": "Dr. Jake Simson, a Partner of the Adviser, serves on the Issuer's board of directors."
},
{
"tickers": [
"PBLS"
],
"issuer_cik": "0001657677",
"owner_cik": "0001384859",
"accession_number": "0001231919-26-000779",
"form_type": "4",
"filing_date": "2026-07-22",
"period_of_report": "2026-07-20",
"issuer_name": "Parabilis Medicines, Inc.",
"issuer_trading_symbol": "PBLS",
"owner_name": "Kolchinsky Peter",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Voting Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-07-21",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 6504,
"transaction_price_per_share": 29.17,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 26444713,
"transaction_value": 189721.68000000002,
"direct_or_indirect": "I",
"nature_of_ownership": "See footnotes",
"footnotes": [
{
"id": "F6",
"description": "The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $28.83 to $29.79 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."
},
{
"id": "F2",
"description": "RA Capital Management, L.P. (the \"Adviser\") is the investment manager for RA Capital Healthcare Fund, L.P. (the \"Fund\") and RA Capital Nexus Fund III, L.P. (the \"Nexus Fund III\"). The general partner of the Adviser is RA Capital Management GP, LLC (the \"Adviser GP\"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein."
},
{
"id": "F3",
"description": "Held directly by the Fund."
}
],
"remarks": "Dr. Jake Simson, a Partner of the Adviser, serves on the Issuer's board of directors."
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 15 records
- Other15 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.
Frequently asked questions
How current is PBLS’s insider data?
These are PBLS Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track PBLS insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for PBLS every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.